로딩 중…
지수 로딩 중…
Scholar Rock Holding Corporation
SRRK· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$45.85-3.07%
2026-08-03
Financials
Valuation Metrics
Scholar Rock Holding Corporation's Market Cap is $5.49B. At end of 2025 it was $5.05B. Ranked #1326 of 3,112 in US market (top 43%), #446 of 1,445 on NASDAQ (top 31%), #77 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 29%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.49B | US#1,326/3,112 Sec#77/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-409M | US—/3,112 Sec—/269 |
| Total Assets | $535M | US#2,716/3,112 Sec#146/269 |
| Net Assets | $276M | US#2,594/3,112 Sec#169/269 |
| Value | ||
| P/B | 19.91x | US#2,812/3,112 Sec#234/269 |
| FCF Yield | -5.53% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -148.08% | US#2,889/3,112 Sec#232/269 |
| ROA | -76.36% | US#3,029/3,112 Sec#254/269 |
| Financial Health | ||
| Debt Ratio | 93.92% | US#1,027/3,112 Sec#166/269 |
| Total Debt | $206M | US#2,180/3,112 Sec#92/269 |
| FCF | $-304M | US#2,787/3,112 Sec#240/269 |
| Cash | $431M | US#1,168/3,112 Sec#64/269 |
| Current Ratio | 8.64x | US#289/3,112 Sec#93/269 |
| Performance | ||
| 1Y Return | 26.10% | US#1,352/3,112 Sec#156/269 |
| 1M Return | -16.45% | US#2,868/3,112 Sec#216/269 |
| From 52W High | -21.61% | US#1,792/3,112 Sec#117/269 |
| 1Y MDD | -34.86% | US#1,681/3,112 Sec#110/269 |
| Trading | ||
| Volume | 874,104 shares | US#1,599/3,112 Sec#153/269 |
| Trading Value | $41M | US#1,502/3,112 Sec#97/269 |
| Per Share | ||
| EPS | $-3.29 | US—/3,112 Sec—/269 |
| BPS | $2.14 | US#2,490/3,112 Sec#172/269 |